TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Waldencast ( (WALD) ) has issued an announcement.
On November 14, 2025, Waldencast plc announced the sale of its rights to the ‘Obagi’ trademark in Japan to Rohto Pharmaceutical Co., Ltd. for $82.5 million. This transaction, along with a new $225 million credit agreement with Lumina Capital Management, strengthens Waldencast’s balance sheet and liquidity position, allowing the company to invest in its Obagi Medical and Milk Makeup brands. These strategic moves are part of Waldencast’s ongoing review to maximize shareholder value and improve its capital structure.
The most recent analyst rating on (WALD) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Waldencast stock, see the WALD Stock Forecast page.
Spark’s Take on WALD Stock
According to Spark, TipRanks’ AI Analyst, WALD is a Neutral.
Waldencast Acquisition’s overall stock score is primarily impacted by its financial performance and valuation. The company shows strong revenue growth and a solid balance sheet, but struggles with profitability and cash flow generation. Technical analysis indicates a bearish trend with potential oversold conditions. The negative P/E ratio and lack of dividend yield further weigh down the score.
To see Spark’s full report on WALD stock, click here.
More about Waldencast
Waldencast plc is a global multi-brand beauty and wellness platform focused on developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. The company aims to build a best-in-class operating platform in the beauty and wellness industry, with a brand-led business model ensuring customer proximity, business agility, and market responsiveness.
Average Trading Volume: 221,070
Technical Sentiment Signal: Sell
Current Market Cap: $218.4M
Find detailed analytics on WALD stock on TipRanks’ Stock Analysis page.